Shengyong Y. Yang
Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications
Identification of a Potent and Selective Small-Molecule Inhibitor Targeting the nNOS-PDZ Domain that Exhibits Rapid In Vivo Antidepressant Efficacy.
Journal: Journal of medicinal chemistry
Published: June 03, 2026
Fragment-Aware Contrastive Learning Framework for Molecular Property Prediction.
Journal: Journal of chemical information and modeling
Published: April 22, 2026
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse models.
Journal: Science translational medicine
Published: February 04, 2026
Discovery and Structure-Activity Relationship Studies of Diazepine Derivatives as a New Class of Ferroptosis Inhibitors with Potent Efficacy in the Doxorubicin-Induced Cardiomyopathy Model.
Journal: Journal of medicinal chemistry
Published: January 30, 2026
Discovery of a Potent and Selective Cell-Active Inhibitor of Histidine-N1 Methyltransferase METTL9.
Journal: Angewandte Chemie (International ed. in English)
Published: January 16, 2026
Discovery of Deuterated 3,4-Dihydro-benzo[e][1,4]diazepine-2,5-dione Derivatives as Potent, Selective and Orally Bioavailable ROCK2 Inhibitors.
Journal: Journal of medicinal chemistry
Published: November 25, 2025
Azapeptide-Based SARS-CoV-2 Main Protease Inhibitors: Design, Synthesis, Enzyme Inhibition, Structural Determination, and Antiviral Activity.
Journal: Journal of medicinal chemistry
Published: September 11, 2025
Acquired resistance to immunotherapy by physical barriers with cancer cell-expressing collagens in non-small cell lung cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 11, 2025
A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers.
Journal: Cell
Published: May 28, 2025
Correction to: TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways.
Journal: Signal transduction and targeted therapy
Published: March 04, 2025
Discovery of 4-((quinolin-8-ylthio)methyl)benzamide derivatives as a new class of SARS-CoV-2 nsp13 inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: January 27, 2025
Last Updated: 09/26/2026